» Articles » PMID: 15997443

Prevalence of Family History of Colorectal Cancer in the General Population

Overview
Journal Br J Surg
Specialty General Surgery
Date 2005 Jul 6
PMID 15997443
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Robust estimates of the prevalence of a family history of colorectal cancer in the general population are essential to inform planning of provision for colonoscopic surveillance and for clinical genetics services. However, there is a paucity of high-quality data.

Methods: Computerized record linkage was used to assess systematically the family history of 160 cancer-free community subjects and thereby provide prevalence data that are independent of participant recall. The data set comprised 2664 first- and second-degree relatives of study subjects, with 148 068 years at risk.

Results: Of people in the 30-70 years age range, 9.4 (95 per cent confidence interval (c.i.) 5.8 to 14.9) per cent had a first-degree relative affected by colorectal cancer, and 28.8 (95 per cent c.i. 22.3 to 36.2) per cent had an affected first- or second-degree relative. Between 0 and 3.1 per cent of study subjects merited colonic surveillance, depending on the stringency of the guidelines used.

Conclusion: An appreciable proportion of the general population has a relative affected by colorectal cancer, sufficient to merit screening under certain criteria. In the absence of good-quality evidence supporting colonoscopic surveillance in groups at moderate risk, these data directly inform the planning of services for people with a family history of colorectal cancer. However, the clinical risk and financial implications of screening should be taken into account.

Citing Articles

AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.

Issaka R, Chan A, Gupta S Gastroenterology. 2023; 165(5):1280-1291.

PMID: 37737817 PMC: 10591903. DOI: 10.1053/j.gastro.2023.06.033.


Evidenced-Based Screening Strategies for a Positive Family History.

Kolb J, Ahnen D, Samadder N Gastrointest Endosc Clin N Am. 2020; 30(3):597-609.

PMID: 32439091 PMC: 7302941. DOI: 10.1016/j.giec.2020.02.015.


Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer.

Gupta S, Bharti B, Ahnen D, Buchanan D, Cheng I, Cotterchio M Cancer. 2020; 126(13):3013-3020.

PMID: 32307706 PMC: 7702222. DOI: 10.1002/cncr.32851.


Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Monahan K, Bradshaw N, Dolwani S, DeSouza B, Dunlop M, East J Gut. 2019; 69(3):411-444.

PMID: 31780574 PMC: 7034349. DOI: 10.1136/gutjnl-2019-319915.


Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery J, Ahnen D, Schroy 3rd P, Hampel H, Baxter N, Boland C Cancer. 2016; 122(17):2633-45.

PMID: 27258162 PMC: 5575812. DOI: 10.1002/cncr.30080.